Original Papers- DOH-URA Katsumi -
number of results to view: what to display: sort:
total:128
[2019]
1.Combining autophagy stimulators and cellulose ethers for therapy against prion disease..[Prion.,13(1),(2019),185-196]Hermann Schaetzl, Basant A. Abdulrahman, Waqas Tahir, Katsumi Doh-ura, Sabine Gilch.
10.1080/19336896.2019.1670928
2.Preparation and Characterization of Cellulose Ether Liposomes for the Inhibition of Prion Formation in Prion-Infected Cells..[J Pharm Sci.,108(8),(2019),2814-2820]Nishizawa K, Teruya K, Oguma A, Sakasegawa Y, Schätzl H, Gilch S, Doh-ura K.
10.1016/j.xphs.2019.03.025
3.Cellulose ether treatment in vivo generates chronic wasting disease prions with reduced protease resistance and delayed disease progression..[J Neurochem.,in press.,(2019)]Hannaoui S, Arifin MI, Chang SC, Yu J, Gopalakrishnan P, Doh-ura K, Schatzl HM, Gilch S.
10.1111/jnc.14877
[2018]
4.Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction..[Biochim Biophys Acta Gen Subj.,1863(2),(2018),384-394]Teruya K, Nishizawa K, Oguma A, Sakasegawa Y, Kitamoto T, Doh-ura K.
10.1016/j.bbagen.2018.11.008
[2017]
5.Pyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity..[PLoS One.,12(9),(2017),e0185357-]Teruya K, Oguma A, Nishizawa K, Kamitakahara H, Doh-ura K.
10.1371/journal.pone.0185357.
6.Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells..[J Virol.,91(6),(2017),e01862-16.-]Hamanaka T, Nishizawa K, Sakasegawa Y, Oguma A, Teruya K, Kurahashi H, Hara H, Sakaguchi S, Doh-ura K.
10.1128/JVI.01862-16
[2016]
7.A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents.[PLOS Pathogens,(2016)]Teruya K, Oguma A, Nishizawa K, Kawata M, Sakasegawa Y, Kamitakahara H, Doh-ura K.
8.The Japan Consortium of Prion Disease (JACOP) for patients' registration and clinical studies of Prion diseases in Japan.[PRION,10,(2016),S106-S107]Ishimura Yuko, Tsukamoto Tadashi, Kuwata Kazuo, Yamada Masahito, Doh-ura Katsumi, Tsuboi Yoshio, Sato Katsuya, Nakamura Yoshikazu, Sanjo Nobuo, Tamura Chieko, Mizusawa Hidehiro
http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000374656300150&DestApp=WOS
[2015]
9.Structure–activityanalysisandantiprionmechanismofisoprenoid compounds.[Virology,486,(2015),63-70]TaichiHamanaka,KeikoNishizawa,YujiSakasegawa,KentaTeruya,KatsumiDoh-ura.
10.Anti-prion activityfoundinbeetlegrubhemolymphof Trypoxylus dichotomusseptentrionalis.[Biochemistry andBiophysicsReports,3,(2015),32-37]Hamanaka T, Nishizawa K, Sakasegawa Y, Kurahashi H, Oguma A, Teruya K ,Doh-ura K.
11.Secretin receptor involvement in prion-infected cells and animals..[FEBS Lett.,589(15),(2015),2011-2018]Kimura T, Nishizawa K, Oguma A, Nishimura Y, Sakasegawa Y, Teruya K, Nishijima I, Doh-Ura K.
12.Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells..[BBRC,460(4),(2015),989-995]Teruya K, Wakao M, Sato M, Hamanaka T, Nishizawa K, Funayama Y, Sakasegawa Y, Suda Y, Doh-ura K.
[2014]
13.Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: implications of interferon and phosphodiesterase 4D-interacting protein..[J Virol.,88(8),(2014),4083-4099]Nishizawa K, Oguma A, Kawata M, Sakasegawa Y, Teruya K, Doh-ura K.
10.1128/JVI.03775-13.
14.Detection of Proteinase K-resistant prion protein (PrPres) in mouse neuroblastoma cells..[PSSJ Archives7,(2014),e074-]Kurahashi H, Sakasegawa Y, Doh-ura K.
[2013]
15.Amyloid-Binding Compounds and their Anti-Prion Potency..[Curr Top Med Chem.,13(19),(2013),2522-2532]Teruya K, Doh-ura K.
[2012]
16.Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion..[Neuropathology,32(2),(2012),124-132]Honda H, Sasaki K, Minaki H, Masui K, Suzuki SO, Doh-Ura K, Iwaki T
[2011]
17.Binding and Selectivity of the Marine Toxin Neodysiherbaine A and Its Synthetic Analogues to GluK1 and GluK2 Kainate Receptors..[J Mol Biol,413(3),(2011),667-683]Unno M, Shinohara M, Takayama K, Tanaka H, Teruya K, Doh-Ura K, Sakai R, Sasaki M, Ikeda-Saito M
18.Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position..[Eur J Med Chem,46(7),(2011),2917-2929]Nguyen Thuy, Sakasegawa Yuji, Doh-Ura Katsumi, Go Mei-Lin
19.Anti-prion activity of protein-bound polysaccharide K in prion-infected cells and animals..[Biochem Biophys Res Commun,405(2),(2011),285-290]Hamanaka Taichi, Sakasegawa Yuji, Ohmoto Akihiro, Kimura Tomohiro, Ando Takao, Doh-Ura Katsumi
[2010]
20.Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells..[Protein J,29(7),(2010),493-500]Teruya Kenta, Nishizawa Keiko, Doh-ura Katsumi
Page: [1] [2] [3] [4] [5] [6] [7] [next]
BackTop
copyright(c)2005 Tohoku University